Topic Statement: Glenmark Pharma, despite a minor correction, remains on a bullish trajectory with strong support levels.
Key Points: 1. A head and shoulders pattern led to a price breakdown and a brief correction. 2. The stock found support at the uptrend line, maintaining its bullish structure. 3. The price is at the 38.2% retracement level, a key support area previously held in July and August 2024.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.